Global Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Market Size, Share, Growth Analysis, By Type(Penicillins, Tetracyclines, Sulfonamides, Macrolides), By Application(Veterinary Hospitals & Clinics, Veterinary Pharmacies, Online Pharmacies and Others.), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2329 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 66 | Figures: 75

Animal Antibiotics and Antimicrobials Market Insights

Animal Antibiotics and Antimicrobials Market size was valued at USD 4.47 billion in 2022 and is poised to grow from USD 4.62 billion in 2023 to USD 6.09 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024-2031)

The global animal antibiotics and antimicrobials market is a vital component of the veterinary pharmaceutical industry, aimed at promoting animal health and welfare. One of the primary drivers of the global animal antibiotics and antimicrobials market is the increasing demand for animal protein. With the growing global population and rising disposable incomes, there has been a significant rise in the consumption of meat, milk, and eggs. This has led to the expansion of livestock production, thereby driving the need for antibiotics and antimicrobials to prevent and treat infectious diseases in animals.

Another factor contributing to market growth is the rising prevalence of animal diseases. Infectious diseases, such as respiratory infections, gastrointestinal infections, and mastitis, pose a significant threat to animal health and productivity. Antibiotics and antimicrobials play a crucial role in controlling and managing these diseases, thus fueling the demand in the market. Moreover, there is an increasing focus on animal welfare and the reduction of disease transmission from animals to humans. Antibiotics and antimicrobials are essential in maintaining the health and well-being of animals, ensuring their optimal growth and productivity.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Animal Antibiotics and Antimicrobials Market size was valued at USD 4.47 billion in 2022 and is poised to grow from USD 4.62 billion in 2023 to USD 6.09 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024-2031)

The competitive landscape is shaped by various factors, including research and development activities, technological advancements, pricing strategies, and marketing initiatives. Key market players focus on product innovation and development to meet the evolving needs of the veterinary healthcare sector. They invest significantly in research to develop new antibiotic formulations and alternative antimicrobial agents that are effective and safe for animal use. 'Zoetis Inc. (United States)', 'Merck Animal Health (United States)', 'Elanco Animal Health (United States)', 'Boehringer Ingelheim Animal Health (Germany)', 'Ceva Santé Animale (France)', 'Vetoquinol S.A. (France)', 'Bayer Animal Health (Germany)', 'Virbac (France)', 'Dechra Pharmaceuticals (United Kingdom)', 'Norbrook Laboratories Ltd. (United Kingdom)', 'Huvepharma (Bulgaria)', 'Phibro Animal Health Corporation (United States)', 'China Animal Husbandry Co., Ltd. (China)', 'Hester Biosciences Limited (India)', 'Indian Immunologicals Ltd. (India)', 'Hipra (Spain)', 'Bimeda Holdings Plc (Ireland)', 'Kyoritsu Seiyaku Corporation (Japan)', 'Vétoquinol (Japan)', 'Ouro Fino Saúde Animal (Brazil)'

The occurrence of infectious diseases among animals, such as avian influenza, foot-and-mouth disease, and swine fever, underscores the necessity of using antibiotics and antimicrobials to control and prevent the spread of diseases. The potential economic losses associated with disease outbreaks drive the demand for these products, particularly in regions where the prevalence of such diseases is high. This demand stems from the need to protect animal health and maintain productivity within the livestock industry.

Growing Emphasis on Antibiotic Alternatives and Responsible Use of Antimicrobials. With the rising concerns over antimicrobial resistance (AMR) and its impact on human and animal health, there is a shift towards reducing the use of antibiotics in animal production. This trend is driven by regulatory initiatives, consumer awareness, and a push from industry stakeholders to find effective alternatives that promote animal health while minimising the risk of AMR. Antibiotic alternatives such as probiotics, prebiotics, phytogenics, and vaccines are gaining traction as viable options to maintain animal health and improve performance.

Analysing the regional insights of the global animal antibiotics and antimicrobials market, the most dominant region is North America. The region has a well-established animal agriculture industry and stringent regulations governing the use of antibiotics and antimicrobials in animal health. The North American market is characterised by the presence of major market players, advanced veterinary healthcare infrastructure, and a high level of awareness regarding animal health and welfare. These factors contribute to the dominance of North America in the global Animal Antibiotics and Antimicrobials market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Animal Antibiotics and Antimicrobials Market

Report ID: SQMIG35A2329

$5,300
BUY NOW GET FREE SAMPLE